| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Atyr Pharma Inc (ATYR) has 4 insiders with recent SEC Form 4 filings, including 16 buys and 0 sells. ATYR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.50M | $646.5K | - | |
| Dir | 1.41M | $609.0K | - | |
| CFO | 412.5K | $177.8K | - | |
| Other | 412.5K | $177.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 24, 2017 | Mendlein John50 | CEO And Director | Buy | 124 | $3.00 | $372.00 | - | |
| Apr 20, 2017 | Mendlein John50 | CEO And Director | Buy | 2,552 | $3.00 | $7,656.00 | +0.4% | |
| Dec 21, 2016 | Schimmel Paul53 | Director | Buy | 25,000 | $2.28 | $56,928.00 | +1.8% | |
| Dec 20, 2016 | Amanullah Ashraf | Vice President, Manufacturing | Buy | 11,000 | $2.25 | $24,748.90 | New | |
| Dec 19, 2016 | Mendlein John50 | CEO And Director | Buy | 69,000 | $2.20 | $151,662.00 | +27.0% | |
| Dec 16, 2016 | Schimmel Paul53 | Director | Buy | 50,000 | $2.48 | $123,885.00 | +3.7% | |
| May 11, 2016 | Matsuoka Grove | See Remarks | Buy | 12,412 | $3.04 | $37,728.96 | +514.6% | |
| Apr 14, 2016 | Schimmel Paul53 | Director | Buy | 66,219 | $4.18 | $276,933.57 | +24.5% | |
| Apr 13, 2016 | Schimmel Paul53 | Director | Buy | 9,835 | $3.85 | $37,864.75 | +4.1% | |
| Apr 12, 2016 | Schimmel Paul53 | Director | Buy | 9,127 | $3.71 | $33,901.39 | +3.6% |